<i>Becn1</i>^F121A improves the survival rate of PDAPP AD mice. by Altea Rocchi (3278457)

Subjects:

Maintenance of a single Zeb2 wt allele rescues PB cytopenia and severe differentiation defects in Zeb1/2 DKO HSPCs. by Jueqiong Wang (11467505)

Effects of SNPs on the Protein Stability, Increasing or Decreasing. by Mirza Jawad Ul Hasnain (8351388)

Nitrotyrosination of gp34 significantly decreases both its binding affinity and stabilization capacity of the H-2K^b complex. by Chaithanya Madhurantakam (329447)

BH3 Peptides induces a decrease in mitochondrial membrane potential but does not engage the Permeability Transition Pore. by Emelyn H. Shroff (163459)

Production of semaphorin-7A in the NIH3T3 fibroblast cell line decreases expression of periostin and fibronectin. by Stephane Esnault (24104)

“…<p>The NIH3T3 fibroblast cell line was transfected with 0.75 μg of plasmid control (pcDNA) or semaphorin-7A-expressing plasmid (pSEMA7A) for 24h. Cells were subsequently starved for 24 h and then activated with TGF-ß1 (1ng/ml) or left untreated for 24 h. …”

Decrease of p38 MAPK phosphorylation in HL60 and KG1a cells exposed to 5-Fluorouridine (FUrd) after cell pretreatment with p38 MAPK pathway inhibitor SB202190. by Sabine Matou-Nasri (2938941)

“…<p>The KG1a and HL60 cells were pre-treated with 10 μM SB202190 for 2 h incubation then followed by the cell treatment with 10 μM of FUrd. …”

MSC treatment does not affect chronic LPS-induced decreased lung function. by P. Padmini S. J. Khedoe (4436458)

ASO treatment suppresses the palbociclib-mediated induction of MEG3 and decrease in cell proliferation in A549 cells. by Traci L. Kruer (3342425)

Dexamethasone (DEX)-induced transient <i>CPK31</i> expression caused a decrease in As(III) tolerance. by Ruijie Ji (3839032)

Adiposity is increased and osteoblast-occupied bone surface is decreased within the external fracture callus during late stage healing in HFD-fed mice. by Matthew L. Brown (431187)

cAMP and PKA/AKAP1 decrease mobility and promote mitochondrial translocation of Drp1. by Ronald A. Merrill (224222)

A visual plot of the Condition × Mindset interaction for the Block 1 error data (left panel) with data points (right panel). by Nicholas P. Carruth (16469743)

Image5_Orally Administered Probiotics Decrease Aggregatibacter actinomycetemcomitans but Not Other Periodontal Pathogenic Bacteria Counts in the Oral Cavity: A Systematic Review and Meta-Analysis.TIF by Thanyaporn Sang-Ngoen (11241888)

“…</p><p>Results: The results showed a significant decrease in the overall count of Aggregatibacter actinomycetemcomitans in the probiotic-treated group compared to the control at 4 weeks (SMD: −0.28; 95% CI: −0.56–−0.01; p = 0.045) but not later. …”

Table5_Orally Administered Probiotics Decrease Aggregatibacter actinomycetemcomitans but Not Other Periodontal Pathogenic Bacteria Counts in the Oral Cavity: A Systematic Review and Meta-Analysis.DOCX by Thanyaporn Sang-Ngoen (11241888)

“…</p><p>Results: The results showed a significant decrease in the overall count of Aggregatibacter actinomycetemcomitans in the probiotic-treated group compared to the control at 4 weeks (SMD: −0.28; 95% CI: −0.56–−0.01; p = 0.045) but not later. …”

Table5_Orally Administered Probiotics Decrease Aggregatibacter actinomycetemcomitans but Not Other Periodontal Pathogenic Bacteria Counts in the Oral Cavity: A Systematic Review and Meta-Analysis.DOCX by Thanyaporn Sang-Ngoen (11241888)

“…</p><p>Results: The results showed a significant decrease in the overall count of Aggregatibacter actinomycetemcomitans in the probiotic-treated group compared to the control at 4 weeks (SMD: −0.28; 95% CI: −0.56–−0.01; p = 0.045) but not later. …”

Image5_Orally Administered Probiotics Decrease Aggregatibacter actinomycetemcomitans but Not Other Periodontal Pathogenic Bacteria Counts in the Oral Cavity: A Systematic Review and Meta-Analysis.TIF by Thanyaporn Sang-Ngoen (11241888)

“…</p><p>Results: The results showed a significant decrease in the overall count of Aggregatibacter actinomycetemcomitans in the probiotic-treated group compared to the control at 4 weeks (SMD: −0.28; 95% CI: −0.56–−0.01; p = 0.045) but not later. …”

Compounds decrease polyQ toxicity in a <i>pqe-1</i> independent manner in aged animals. by Cindy Voisine (30589)

PGC-1β KO mice show a specific decrease in Mfn2 expression in skeletal muscle. by Marc Liesa (35879)

dnMAML increases the proportion of bone mass within the callus due to a moderate decrease in callus size. by Michael I. Dishowitz (430286)

“…(<b>D</b>) There are no differences in bone volume (BV) or (<b>F</b>) average osseous bone tissue area (Avg BA) at any time point. μCT images were acquired at a 21 µm voxel size. …”